I 
113TH CONGRESS 
1ST SESSION H. R. 1074 
To amend the Public Health Service Act to foster more effective implementa-
tion and coordination of clinical care for people with pre-diabetes and 
diabetes. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 12, 2013 
Mr. OLSON (for himself, Mr. MORAN, Mr. SESSIONS, Mr. ROE of Tennessee, 
Mr. MAFFEI, and Ms. TSONGAS) introduced the following bill; which was 
referred to the Committee on Energy and Commerce 
A BILL 
To amend the Public Health Service Act to foster more 
effective implementation and coordination of clinical care 
for people with pre-diabetes and diabetes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘National Diabetes 
Clinical Care Commission Act’’. 
SEC. 2. FINDINGS. 
Congress finds the following: 
(1) The Centers for Disease Control and Pre-
vention report that nearly 26,000,000 Americans 
VerDate Mar 14 2013 
16:06 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS
have 
diabetes 
in 
addition 
to 
an 
estimated 
79,000,000 American adults that have pre-diabetes, 
an increase of 2,000,000 Americans with diabetes 
and 22,000,000 American adults with pre-diabetes 
since 2008. 
(2) Diabetes affects 8.3 percent of Americans of 
all ages and 11.3 percent of adults age 20 and older. 
Individuals of racial and ethnic minorities continue 
to have higher rates of diabetes than individuals not 
of such minorities, as demonstrated by the following: 
16.1 percent of all adult American Indians and Alas-
kan Natives have diabetes; 12.6 percent of all adult 
African-Americans have diabetes; 11.8 percent of all 
adult Hispanics have diabetes; and 8.4 percent of all 
adult Asian-Americans have diabetes, while 7.1 per-
cent of all non-Hispanic Whites have diabetes. 
(3) Diabetes is the seventh leading cause of 
death in the United States. 
(4) People with diabetes are more likely than 
people without diabetes to have heart attacks, 
strokes, high blood pressure, kidney failure, blind-
ness, and require amputations. 
(5) Total national costs associated with diabetes 
in 2007 exceeded $174,000,000,000, according to 
the Centers for Disease Control and Prevention. 
VerDate Mar 14 2013 
16:06 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS
(6) One in three Medicare dollars is currently 
spent on people with diabetes. 
(7) The Centers for Disease Control and Pre-
vention projects that as many as 1 in 3 American 
adults could have diabetes by 2050 if current trends 
continue. 
(8) There are 35 Federal departments, agen-
cies, and offices involved in the implementation of 
Federal diabetes activities. 
SEC. 3. ESTABLISHMENT OF THE NATIONAL DIABETES 
CLINICAL CARE COMMISSION. 
Part P of title III of the Public Health Service Act 
(42 U.S.C. 280g et seq.) is amended by adding at the end 
the following new section: 
‘‘SEC. 399V–6. NATIONAL DIABETES CLINICAL CARE COM-
MISSION. 
‘‘(a) ESTABLISHMENT.—There is hereby established 
within the Department of Health and Human Services the 
National Diabetes Clinical Care Commission (in this sec-
tion referred to as the ‘Commission’) to evaluate and make 
recommendations regarding better coordination and 
leveraging of programs within the Department of Health 
and Human Services and other Federal agencies that re-
late in any way to supporting appropriate clinical care 
(such as any interactions between physicians and other 
VerDate Mar 14 2013 
16:06 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS
health care providers and their patients with pre-diabetes 
and diabetes where care is rendered for the management 
of their pre-diabetes or diabetes or its complications) for 
people with pre-diabetes and diabetes. 
‘‘(b) MEMBERSHIP.— 
‘‘(1) IN GENERAL.—The Commission shall be 
composed of the following voting members: 
‘‘(A) The heads (or their designees) of the 
following Federal agencies and departments 
that conduct programs that could impact the 
clinical care of people with pre-diabetes and dia-
betes: 
‘‘(i) The Centers for Medicare and 
Medicaid Services. 
‘‘(ii) The Agency for Healthcare Re-
search and Quality. 
‘‘(iii) The Centers for Disease Control 
and Prevention. 
‘‘(iv) The Indian Health Service. 
‘‘(v) The Department of Veterans Af-
fairs. 
‘‘(vi) The National Institutes of 
Health. 
‘‘(vii) The Food and Drug Adminis-
tration. 
VerDate Mar 14 2013 
16:06 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS
‘‘(viii) The Health Resources and 
Services Administration. 
‘‘(ix) The Department of Defense. 
‘‘(x) Other governmental or non-
governmental agency heads, at the discre-
tion of the agency, that impact clinical 
care of individuals with pre-diabetes and 
diabetes. 
‘‘(B) Twelve additional voting members ap-
pointed under paragraph (2). 
‘‘(2) ADDITIONAL MEMBERS.—The Commission 
shall include additional voting members appointed by 
the Comptroller General of the United States, in 
consultation with national medical societies and pa-
tient advocate organizations with expertise in diabe-
tes and the care of patients with diabetes, including 
one or more from each of the following categories: 
‘‘(A) Clinical endocrinologists. 
‘‘(B) Physician specialties (other than as 
described in subparagraph (A)) that play a role 
in diabetes care or their complications. 
‘‘(C) Primary care physicians. 
‘‘(D) Non-physician health care profes-
sionals, such as certified diabetes educators, 
VerDate Mar 14 2013 
16:06 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS
clinical dieticians, nurses, nurse practitioners, 
and physician assistants. 
‘‘(E) Patient advocates. 
‘‘(F) National experts in the duties listed 
under subsection (c). 
‘‘(3) CHAIRPERSON.—The voting members of 
the Commission shall select a chairperson from the 
members described in paragraph (2)(A). 
‘‘(4) MEETINGS.—The Commission shall meet 
at least twice, and not more than 4 times, a year. 
‘‘(5) BOARD TERMS.—Members of the Commis-
sion, including the chairperson, shall serve for a 3- 
year term. A vacancy on the Commission shall be 
filled in the same manner as the original appoint-
ments. 
‘‘(c) DUTIES.—The Commission shall— 
‘‘(1) evaluate programs of the Department of 
Health and Human Services regarding the utiliza-
tion of diabetes screening benefits, annual wellness 
visits, and other preventive health benefits that may 
reduce the risk of diabetes and its complications, ad-
dressing any existing problems regarding such utili-
zation and related data collection mechanisms; 
‘‘(2) identify current activities and critical gaps 
in Federal efforts to support clinicians in providing 
VerDate Mar 14 2013 
16:06 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS
integrated, high-quality care to people with pre-dia-
betes and diabetes; 
‘‘(3) make recommendations regarding the co-
ordination of clinically based activities that are being 
supported by the Federal Government; 
‘‘(4) make recommendations regarding the de-
velopment and coordination of federally funded clin-
ical practice support tools for physicians and other 
health care professionals in caring for and managing 
the care of people with pre-diabetes and diabetes; 
‘‘(5) evaluate programs in existence as of the 
date of the enactment of this section and determine 
if such programs are meeting the needs identified in 
paragraph (2) and, if such programs are determined 
to not be meeting such needs, recommend programs 
that would be more appropriate; 
‘‘(6) recommend how an outcomes-based reg-
istry may be developed and then used to evaluate 
various care models and methods and the impact of 
such models and methods on diabetes management 
as measured by appropriate care parameters (such 
as A1C, blood pressure, and cholesterol levels); 
‘‘(7) evaluate and expand education and aware-
ness to physicians and other health care profes-
VerDate Mar 14 2013 
16:06 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS
sionals regarding clinical practices for the prevention 
of diabetes and the precursor conditions of diabetes; 
‘‘(8) review and recommend appropriate meth-
ods for outreach and dissemination of educational 
resources that regard diabetes prevention and treat-
ments, are funded by the Federal Government, and 
are intended for health care professionals and the 
public; and 
‘‘(9) include other activities, such as those re-
lating to the areas of public health and nutrition, 
that the Commission deems appropriate. 
‘‘(d) OPERATING PLAN.— 
‘‘(1) INITIAL PLAN.—Not later than 90 days 
after its first meeting, the Commission shall submit 
to the Secretary and the Congress an operating plan 
for carrying out the activities of the Commission as 
described in subsection (c). Such operating plan may 
include— 
‘‘(A) a list of specific activities that the 
Commission plans to conduct for purposes of 
carrying out the duties described in each of the 
paragraphs in subsection (c); 
‘‘(B) a plan for completing the activities; 
‘‘(C) a list of members of the Commission 
and other individuals who are not members of 
VerDate Mar 14 2013 
16:06 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS
the Commission who will need to be involved to 
conduct such activities; 
‘‘(D) an explanation of Federal agency in-
volvement and coordination needed to conduct 
such activities; 
‘‘(E) a budget for conducting such activi-
ties; 
‘‘(F) a plan for evaluating the value and 
potential impact of the Commission’s work and 
recommendations, including the possible con-
tinuation of the Commission for the purposes of 
overseeing their implementation; and 
‘‘(G) other information that the Commis-
sion deems appropriate. 
‘‘(2) UPDATES.—The Commission shall periodi-
cally update the operating plan under paragraph (1) 
and submit such updates to the Secretary and the 
Congress. 
‘‘(e) FINAL REPORT AND SUNSET OF THE COMMIS-
SION.—By not later than 3 years after the date of the 
Commission’s first meeting, the Commission shall submit 
to the Secretary and the Congress a report containing all 
of the findings and recommendations of the Commission. 
Not later than 120 days after the submission of the final 
report, the Secretary shall review the evaluation required 
VerDate Mar 14 2013 
16:06 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS
under subsection (d)(1)(F) to determine the continuation 
of the Commission. 
‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—Appro-
priations are authorized to be made available to the Com-
mission for each of fiscal years 2013, 2014, and 2015, 
from amounts otherwise made available to the Department 
of Health and Human Services for such fiscal years, to 
carry out this section.’’. 
Æ 
VerDate Mar 14 2013 
21:45 Mar 14, 2013
Jkt 029200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6301
E:\BILLS\H1074.IH
H1074
tkelley on DSK3SPTVN1PROD with BILLS